10.2 Drugs used in neuromuscular disorders

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

74 library items in 10.2 Drugs used in neuromuscular disorders

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

10: Musculoskeletal and joint diseases (remove) , 10.2 Drugs used in neuromuscular disorders (remove)

Sort by: Display summary:

Results 1 - 10 of 74

Result page:
Previous
|
1
2
3
4
5
6
7
8
|
Next

1.

SMC unable to recommend fampridine (Fampyra®) for improvement of walking in adult patients with multiple sclerosis with walking disability due to non-submission

Source: Scottish Medicines Consortium (SMC),
Date published: 10/04/2012

Category:

10.2.1 Drugs that enhance neuromuscular transmission | Drug reviews | Multiple sclerosis

NeLM Area:

Evidence > Drug Specific Reviews

Link
2.

NETAG issues recommendation on fampridine (Fampyra®) in multiple sclerosis

Source: NETAG ,
Date published: 26/03/2012

Category:

10.2.1 Drugs that enhance neuromuscular transmission | Drug reviews | Multiple sclerosis

NeLM Area:

Evidence > Drug Specific Reviews

Link to recommendation

Link to appraisal report
3.

Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential

Source: Clinical Pharmacology and Therapeutics,
Date published: 01/03/2012

Category:

10.2.2 Skeletal muscle relaxants

NeLM Area:

Evidence > Medicines Management > References

Abstract link
4.

Content variability of active drug substance in compounded oral 3,4-diaminopyridine products

Source: Journal of Clinical Pharmacy and Therapeutics,
Date published: 06/02/2012

Category:

10.2.1 Drugs that enhance neuromuscular transmission | Pharmaceutics

NeLM Area:

Evidence > Medicines Management > References

Abstract link
5.

How do you convert an oral pyridostigmine dose to a parenteral neostigmine dose?

Source: London Medicines Information Service,
Date published: 27/01/2012
Review date: 31/01/2014

Category:

10.2.1 Drugs that enhance neuromuscular transmission | FAQs | Neuromuscular disease

NeLM Area:

Evidence > Medicines Q & A

248.2final.doc
6.

10.2 Drugs used in neuromuscular disorders

Source: St. George's Healthcare NHS Trust,
Date published: 13/12/2011

Category:

10.2 Drugs used in neuromuscular disorders

NeLM Area:

Formularies > Trusts > St George's Healthcare NHS Trust Formulary > Products > Approved Prescribing List > 10: Musculoskeletal and joint diseases
7.

Study looks at associations between medication use and nocturnal leg cramps

Source: Arch Internal Med,
Date published: 13/12/2011

Category:

2.2 Diuretics | 3.1.1 Adrenoceptor agonists | 10.2.2 Skeletal muscle relaxants | Adverse Drug Reactions | Rheumatology

NeLM Area:

News

Link (abstract)
8.

NETAG issues recommendation on amifampridine phosphate (Firdapse®) for the symptomatic treatment of Lambert-Eaton Myasthenic Syndrome

Source: North East Treatment Advisory Group,
Date published: 05/12/2011

Category:

10.2.1 Drugs that enhance neuromuscular transmission | Drug reviews | Neuromuscular disease

NeLM Area:

Evidence > Drug Specific Reviews

Appraisal report

Recommendation
9.

NICE clinical guideline consultation: Spasticity in children and young people

Source: NICE,
Date published: 19/10/2011

Category:

10.2.2 Skeletal muscle relaxants | Clinical guidelines | National Institute of Clinical Excellence (NICE) | Neuromuscular disease

NeLM Area:

News

Link
10.

What is the difference between amifampridine and 3,4-diaminopyridine base for Lambert-Eaton myasthenic syndrome in adults?

Source: Wessex Drug and Medicines Information Centre,
Date published: 12/09/2011
Review date: 31/05/2012

Category:

10.2.1 Drugs that enhance neuromuscular transmission | FAQs | Neuromuscular disease

NeLM Area:

Evidence > Medicines Q & A

QA333_3amifampridine.doc

Results 1 - 10 of 74

Result page:
Previous
|
1
2
3
4
5
6
7
8
|
Next